Department of Defense December 1, 2017 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting
The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel).
Notice of a Pilot Program on Medication Therapy Management Under the TRICARE Program
Per Section 726 of the National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2015, the Department of Defense (DoD) is implementing a 2-year Pilot Program, ``Pilot Program on Medication Therapy Management Under TRICARE Program''. The Pilot Program will provide Medication Therapy Management (MTM) services to promote adherence and improve medication-related health outcomes for TRICARE beneficiaries (Beneficiaries) with more than one chronic medical condition and taking more than one medication. The Pilot Program will be conducted in three types of pharmacy settings. The intent of this Pilot Program is to evaluate the feasibility and desirability of including MTM as part of the TRICARE Program.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
